Local tumour control and patient survival after ruthenium-106 brachytherapy for small choroidal melanoma.

Beatrice GalloRohan HussainRanaa Al-JamalHagar KhalidIan StokerGordon HayAmit K AroraPeter W SzlosarekMandeep S Sagoo

Published in: The British journal of ophthalmology (2024)

Small CMs treated with Ru-106 brachytherapy show recurrence and death rates of 17% and 2% at 5 years and 26% and 8% at 10 years. As small CMs have better prognosis than large tumours, early treatment is the key for better survival outcomes.

Keyphrases

high dose
radiation therapy
locally advanced
optical coherence tomography
low dose
rectal cancer
newly diagnosed
quantum dots
skin cancer